专题:Lipoproteins and Cardiovascular Health

This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
最新文献
Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

review Full Text OpenAlex

Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?

review Full Text OpenAlex

Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia

article Full Text OpenAlex

The Emerging Potential of Apolipoprotein C-III Inhibition for ASCVD Prevention: A State-of-the-Art Review

review Full Text OpenAlex

PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression

review Full Text OpenAlex

Aspirin for Secondary Prevention of Atherosclerosis—Evidence or Dogma?

article Full Text OpenAlex

Demographic diversity in platelet function and response to antiplatelet therapy

review Full Text OpenAlex

Doubts over landmark heart drug trial: ticagrelor PLATO study

article Full Text OpenAlex

HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer’s-associated markers

article Full Text OpenAlex

Clinical significance of small dense low‐density lipoprotein cholesterol measurement in type 2 diabetes

review Full Text OpenAlex

近5年高被引文献
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

article Full Text OpenAlex 5459 FWCI910.83603324

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

article Full Text OpenAlex 1332 FWCI237.2279377

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

article Full Text OpenAlex 1024 FWCI310.52944387

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

article Full Text OpenAlex 858 FWCI124.11827559

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

article Full Text OpenAlex 785 FWCI155.10079528

Global epidemiology of dyslipidaemias

review Full Text OpenAlex 767 FWCI146.45583292

Pathophysiology of Atherosclerosis

review Full Text OpenAlex 750 FWCI88.68813276

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

article Full Text OpenAlex 699 FWCI350.59997933

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

article Full Text OpenAlex 572 FWCI102.46823032

The Role of Inflammation in Cardiovascular Disease

review Full Text OpenAlex 535 FWCI63.2980548